The Drug Controller General of India has approved a human trial for the country's first mRNA technology vaccine. The Ministry of Earth Science gave this information on Friday. The vaccine named HGCO19 has been developed by Genova, a Pune-based company.
Genova has developed this vaccine in collaboration with US company HDT Biotech Corporation. The vaccine has been successfully tested on animals. Antibodies have been claimed to be prepared in animals after their dose. HGCO19 can be protected for two months at a temperature of two to eight degrees Celsius.
The Pfizer and Biotech vaccines were also made on this technique.
Pfizer and Biotech vaccines have been approved in the UK. Another American company Moderna has also sought approval for the emergency use of the vaccine. Both these vaccines have been developed on technology based on messenger-RNA ie mRNA and both are also up to 95% effective.
Such vaccines use mRNA, which tells the body what kind of protein to make to fight the virus.
First time-based vaccine on mRNA technology
mRNA or messenger-RNA is a small part of the genetic code that makes proteins in our cells (cells). It can also be understood in easy language that when a virus or bacteria attacks our body, mRNA technology sends a message to our cells to make proteins to fight that virus or bacteria.
With this, our immune system gets the protein it needs and makes antibodies in our body. Its biggest advantage is that it can make vaccines more quickly than conventional vaccines. Along with this, the immunity of the body is also strengthened. This is the first time a vaccine based on mRNA technology is being created in the world.
Biggest player of India Vaccine Market
Only 60% of the vaccine sold worldwide is produced in India. India's pharma sector is worth around Rs 2.9 lakh crore. Pune-based Serum Institute of India (SII) is the world's largest vaccine manufacturer. In India, apart from Pfizer, Bharat Biotech, the Serum Institute of India (SII) has sought emergency approval for the vaccine covishield of Oxford University and AstraZeneca.
Kolkata The Election Commission has asked West Bengal BJP President Dilip Ghosh to clarify his st
More than 3 lakh new corona cases have come in the country for the fifth consecutive day. Accordi
India's eye on AY.4.2 variant of Corona, Health Minister Hole - investigation is going on
On the approval of Covaxin from the World Health Organization, Union Health Minister Mansukh Mand
Comedian Kunal Kamra is constantly in the headlines after making controversial comments about Mah
The market for cryptocurrencies is considered volatile and risky. Here is one moment a man reache
A bumper discount is available on Smart TV on Amazon. There is a discount of 51% on the recently
Shubman Gill: Injured or rested? Fans react to Gill's exclusion from the T20 series.
Speculation is rife after Indian T20 team vice-captain Shubman Gill was ruled out of the fourth T
It is said that if your intentions are good and your courage is high, then one-day success will k
The second season of Sri Lanka's T-20 tournament Lanka Premier League (LPL), which was started on
It has been five months since the Russia-Ukraine war, but on Wednesday the Russian military conti
